Gottlieb: Why FDA Must Help Restore Puerto Rico's Pharma Sector
FDA commissioner underscores importance of restoring full production in Puerto Rico, where nearly 10% of all pharmaceuticals consumed in the US are made. Some plants have partially resumed operations under generator power, he notes, but the full recovery that at some point will be needed to prevent shortages will require restoring the island's power grid.
You may also be interested in...
US FDA’s drug shortage team continues to check in with sponsors, but so far the infections and quarantines have not impacted drug production.
The race is on in Puerto Rico to avert critical drug shortages that could hit the US in a few months if service from the island's electrical grid hasn't been restored to its pharmaceutical manufacturing facilities, FDA Commissioner Gottlieb tells Congress.
FDA has identified more than 40 high-priority drug products from at least five companies and is offering assistance to resume operations, including 'coordinating transport of certain critical drugs out of Puerto Rico.'